IP
Ionis Pharmaceuticals, Inc.
Every trial this sponsor leads in the registry, and everything it has published.
Recruiting8
Recruited9
Not yet recruiting1
By invitation1
Completed92
Stopped10
Other1
19 active · 16% of this sponsor’s registry footprint
Genetic & Rare Disease4 trials
Neurology3 trials
Immunology & Inflammation2 trials
Metabolic/Endocrine/Nutrition2 trials
Cardiovascular1 trial
Not shown above: 7 trials whose condition matched no therapy area.
Trials by phase
Phase 140
Phase 252
Phase 326
Phase 41
Unphased3
Pipeline by phase · 12 drugs in active development
Phase 3 · 6 drugs
Phase 2 · 1 drug
Phase 1 · 5 drugs
Active trials only, code names and brands merged. 92 completed trials are in the counts above but their drugs are not folded into this pipeline.
Track your drug now for free
We check every one of its trials daily and tell you what moved.
- Status changeStatus moved to completedWas recruiting · always alerts
- Completion date movePrimary completion slipped 210 daysSlips and pull-ins of 30+ days
- New trialNew trial registered in your scopeFirst posted within 30 days
- Enrollment changeEnrollment grew to 1,200Moves of 15%+ or count finalised
- Substantive record editPrimary endpoint redefined from 24 to 52 weeksRead overnight and flagged in plain English
US registryClinicalTrials.gov
EU registryCTIS · Soon